Publisher: Bentham Science Publishers
E-ISSN: 1875-5666|4|2|131-136
ISSN: 1566-5240
Source: Current Molecular Medicine, Vol.4, Iss.2, 2004-03, pp. : 131-136
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
It has long been accepted that high concentrations of glutamate can destroy neurons,and this is the basis of the theory of excitotoxicity during brain injury such as stroke.Glutamate N-methyl- D-aspartate (NMDA)receptor antagonists such as Selfotel,Aptiganel,Gavestinel and others failed to show neuroprotective efficacy in human clinical trials or produced intolerable central nervous system adverse effects.The failure of these agents has been attributed to poor studies in animal models and to poorly designed clinical trials.We also speculate that NMDA receptor anatagonism may have hindered endogenous mechanisms for neuronal survival and neuroregeneration.It remains to be proven in human stroke whether NMDA receptor antagonism can be neuroprotective.
Related content
Common Genetic Conditions of Ischemic Stroke to Keep in Mind
Current Molecular Medicine, Vol. 14, Iss. 8, 2014-09 ,pp. :
Risk relation between rhinitis and acute ischemic stroke
Allergy and Asthma Proceedings, Vol. 36, Iss. 6, 2015-11 ,pp. :
The Migraine-Ischemic Stroke Connection: Potential Pathogenic Mechanisms
Current Molecular Medicine, Vol. 9, Iss. 2, 2009-03 ,pp. :
Rise in Fall Rates Triggers Data-Driven PI Program
Joint Commission Perspectives on Patient Safety, Vol. 3, Iss. 11, 2003-11 ,pp. :